Uraniatx’s website
1 known investors
Urania Therapeutics develops treatments for genetic diseases and cancers caused by nonsense mutations, targeting monogenic diseases in which a single gene defect impairs production of a functional protein. It focuses on rare diseases that collectively affect a large patient population but currently lack curative therapies.
BiotechHealthtech